ES2545577T3 - Método mejorado para el tratamiento con bisulfito - Google Patents
Método mejorado para el tratamiento con bisulfito Download PDFInfo
- Publication number
- ES2545577T3 ES2545577T3 ES07012188.4T ES07012188T ES2545577T3 ES 2545577 T3 ES2545577 T3 ES 2545577T3 ES 07012188 T ES07012188 T ES 07012188T ES 2545577 T3 ES2545577 T3 ES 2545577T3
- Authority
- ES
- Spain
- Prior art keywords
- bisulfite
- dna
- solid phase
- glass
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 title abstract description 20
- 238000000034 method Methods 0.000 title abstract description 8
- 239000011521 glass Substances 0.000 abstract description 7
- 238000006243 chemical reaction Methods 0.000 abstract description 6
- 239000002245 particle Substances 0.000 abstract description 4
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 2
- 239000007790 solid phase Substances 0.000 abstract 4
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- 230000009615 deamination Effects 0.000 abstract 2
- 238000006481 deamination reaction Methods 0.000 abstract 2
- 230000006326 desulfonation Effects 0.000 abstract 2
- 238000005869 desulfonation reaction Methods 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 230000011987 methylation Effects 0.000 abstract 1
- 238000007069 methylation reaction Methods 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- 238000007399 DNA isolation Methods 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000006463 DNA deamination Effects 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012148 binding buffer Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- QPUKANZXOGADOB-UHFFFAOYSA-N n-dodecyl-n-methylnitrous amide Chemical compound CCCCCCCCCCCCN(C)N=O QPUKANZXOGADOB-UHFFFAOYSA-N 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Compounds Of Iron (AREA)
- Saccharide Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
Método para la conversión de una base citosina en un ácido nucleico a una base uracilo, que comprende las etapas de: a) incubar el ácido nucleico en presencia de iones sulfito de manera que el ácido nucleico se desamina, b) unir el ácido nucleico desaminado a una fase sólida, c) lavar opcionalmente el ácido nucleico desaminado unido a la fase sólida, d) incubar el ácido nucleico unido a la fase sólida desaminado bajo condiciones alcalinas de manera que el ácido nucleico desaminado se desulfona, e) lavar opcionalmente el ácido nucleico unido a la fase sólida desaminado y desulfonado, y f) eluir opcionalmente el ácido nucleico desaminado y desulfonado a partir de la fase sólida.
Description
El experimento siguiente demuestra que la PCR que se describe en el instrumento LightCycler® puede utilizarse como herramienta de evaluación del ADN que se trató con bisulfito. Muestra que la combinación iniciador/sonda diseñada da resultados positivos solamente con ADN después del tratamiento con bisulfito. El ADN tratado con bisulfito (en este caso el ADN se trató con bisulfito de acuerdo con el protocolo que se describe en el Ejemplo 2) y el ADN no tratado se amplificaron en paralelo con la utilización de las mismas concentraciones de molde (20ng y 1ng por PCR).
Sonda de hibridación LC FastStart DNA Master Hybridation Probe 1x, MgCl2 2 mM, iniciador directo 0.5μM,iniciador inverso 0.5μM, sonda donadora 250nM, sonda aceptora 250nM, molde 10μl, volumen total de la PCR 20μl.
Desnaturalización 10min/95°C 55 ciclos 95°C/10s 65°C/10s - captación de señal 72°C110s Incremento gradual de la temperatura 20°C/s
1.4 Resultado
- MDNA/PCR
- Tratamiento con bisulfito Valor de CT o Punto de cruce
- imagen11
-
imagen12 imagen13
- 20 ng
- Sí 30.55
- imagen14
-
imagen15 29.72
- imagen16
-
imagen17 29.95
- imagen18
-
imagen19 30.06
- 1 ng
- Sí 34.7
- imagen20
-
imagen21 35.8
- imagen22
-
imagen23 34.07
- imagen24
-
imagen25 33.86
- 20 ng
- No Sin curva de crecimiento
- imagen26
-
imagen27 Sin curva de crecimiento
- imagen28
-
imagen29 Sin curva de crecimiento
- imagen30
-
imagen31 Sin curva de crecimiento
- 1 ng
- No Sin curva de crecimiento
- imagen32
-
imagen33 Sin curva de crecimiento
- imagen34
-
imagen35 Sin curva de crecimiento
- imagen36
-
imagen37 Sin curva de crecimiento
El resultado muestra puntos de cruce solamente para el ADN que se trató con bisulfito. Por lo tanto, esta PCR es adecuada para evaluar los métodos con bisulfito. Para aquellos con experiencia en la materia está claro que podría utilizarse cualquier PCR como herramienta de evaluación si se garantiza que la combinación iniciador/sonda no reacciona con el ADN antes del tratamiento con bisulfito.
2. Ejemplo 2: Reacción del bisulfito mediante la utilización de partículas de vidrio magnéticas (MGPs)
12
2.4.3 Resultados:
- imagen39
- ADN metilado por Método del Bisulfito que se utilizó
- réplicas
- Bisulfito PCR Intergen Método MGP
- imagen40
-
imagen41 imagen42 Valores de CT o Puntos de cruce
- 1
- 30 ng 6 ng 29.90 30.46
- 2
-
imagen43 imagen44 30.07 29.86
- 3
-
imagen45 imagen46 30.07 30.44
- 4
-
imagen47 imagen48 30.14 30.35
- 5
-
imagen49 imagen50 30.22 30.24
- 6
-
imagen51 imagen52 30.26 30.46
- 7
-
imagen53 imagen54 30.31 30.50
- 8
-
imagen55 imagen56 30.19 30.54
- 9
-
imagen57 imagen58 30.03 30.17
- 10
-
imagen59 imagen60 29.85 30.69
- 1
- 6ng 1.2 ng 32.49 32.14
- 2
-
imagen61 imagen62 32.67 32.60
- 3
-
imagen63 imagen64 32.29 32.83
- 4
-
imagen65 imagen66 32.87 32.53
- 5
-
imagen67 imagen68 32.15 32.90
- 6
-
imagen69 imagen70 32.23 32.77
- 7
-
imagen71 imagen72 32.59 32.73
- 8
-
imagen73 imagen74 32.91 33.09
- 9
-
imagen75 imagen76 32.46 32.88
- 10
-
imagen77 imagen78 33.17 32.83
Los valores de CT o puntos de cruce que se calculan durante la PCR en tiempo real son casi idénticos para los dos métodos con bisulfito que se utilizaron, es decir que el desempeño de los métodos es el mismo.
3 Ejemplo 3: Reacción con bisulfito automatizada mediante la utilización de MGPs
Se mezclan y se incuban durante 10 minutos a 37 °C 20 μl de la dilución de ADN metilado (Intergen, que se distribuye por Serologicals Corporation, Norcross, GA, Estados Unidos; Cat S7821) (50 ng/ensayo), 4 μl de una solución de Poli(dA)(concentración 250 ng/ μl) y2.6 μl de NaOH 2 M.
Se mezclan 26 μl de ADN desnaturalizado con 220 μl de reactivo de bisulfito (bisulfito de sodio 2.5M, hidroquinona125mM, pH 5.0) y se incuban durante 4 horas a 50 °C.
Se mezclan 250 μl de ADN desaminado con 600 μl de amortiguador de unión (estuche de aislamiento de ADN MagNAPureDNA Isolation Kit I, Roche, Mannheim, Alemania) y 75 μl de la solución de partículas de vidrio magnéticas (estuche de aislamiento de ADN MagNAPure DNA Isolation Kit I, Roche, Mannheim, Alemania) y se incuban durante 15min/ temperatura ambiente con mezclado continuo. Después de eso, las partículas de vidrio magnéticas se lavan tres
14
Lista de Referencias
Abramson, R. D. y Myers, T. W., Curr Opin Biotechnol 4 (1993) 41-7 Alderton, R. P., y otros, Anal Biochem 201 (1992) 166-9 Ausubel, F., y otros, en "Current protocols in molecular biology" (1994), Eds. F. Ausubel, R. Brent y K. R.E., Wiley & Sons Verlag, Nueva York Barany, F., PCR Methods Appl 1 (1991) 5-16 Barany, F., Proc Natl Acad Sci U S A 88 (1991) 189-93 Benyajati, C., y otros, Nucleic Acids Res 8 (1980) 5649-67 Braunauer, en "The Adsorption of Gases and Vapors" (1943), Princeton University Press Clark, S. J., y otros, Nucleic Acids Res 22 (1994) 2990-7 DE 3724442 DE-A 37 34 442 EP 0 200 362 EP 0 201 184 EP 0 389 063 EP 0 439 182 Feil, R., y otros, Nucleic Acids Res 22 (1994) 695-6 Frommer, M., y otros, Proc Natl Acad Sci U S A 89 (1992) 1827-31 GB 91/00212 Grigg, G. y Clark, S., Bioessays 16 (1994) 431-6 Grigg, G. W., DNA Seq 6 (1996) 189-98 Grunau, C., y otros, Nucleic Acids Res 29 (2001) E65-5 Guatelli, J. C., y otros, Proc Natl Acad Sci U S A 87 (1990) 1874-8 Jakobi, R., y otros, Anal Biochem 175 (1988) 196-201 Komiyama, M. y Oshima, S., Tetrahedron Letters 35 (1994) 8185-8188 Kwoh, D. Y., y otros, Proc Natl Acad Sci U S A 86 (1989) 1173-7 Lottspeich y Zorbas, en "Bioanalytik" (1998), Eds. L. a. Zorbas, Spektrum Akademischer Verlag, Heidelberg, Berlín, Alemania Marko, M. A., y otros, Anal Biochem 121 (1982) 382-7 Morrow, C.S., y otros, Gene 75 (1989), 3-11 Oakeley, E. J., Pharmacol Ther 84 (1999) 389-400 Olek, A., y otros, Nucleic Acids Res 24 (1996) 5064-6 Paulin, R., y otros, Nucleic Acids Res 26 (1998) 5009-10 Raizis, A. M., y otros, Anal Biochem 226 (1995) 161-6 Sambrook, J., y otros, en "Molecular Cloning: A Laboratory Manual" (1989), Eds. J. Sambrook, E. F. Fritsch y T. Maniatis, Cold Spring Harbour Laboratory Press, Cold Spring Harbour, NY Spray Drying Handbook (1991), John Wiley & Sons, Nueva York US 4,683,202 US 5,130,238 US 5,137,806 US 5,210,015 US 5,234,809 US 5,487,972 US 5,552,277 US 5,595,890 US 5,639,611 US 5,786,146 US 5,804,375 US 6,174,670 US 6,331,393 Vogelstein, B. y Gillespie, D., Proc Natl Acad Sci U S A 76 (1979) 615-9 Warnecke, P. M., y otros, Methods 27 (2002) 101-7 Whelen, A. C. y Persing, D. H., Annu Rev Microbiol 50 (1996) 349-73 WO 00/32762 WO 00/37291 WO 01/37291 WO 01/98528 WO 02/31186 WO 90/01069 WO 90/06045 WO 92/02638
18
Claims (1)
-
imagen1 imagen2
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02019097A EP1394172A1 (en) | 2002-08-29 | 2002-08-29 | Improved method for bisulfite treatment |
| EP02019097 | 2002-08-29 | ||
| EP02028114 | 2002-12-18 | ||
| EP02028114 | 2002-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2545577T3 true ES2545577T3 (es) | 2015-09-14 |
Family
ID=32071078
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES07012188.4T Expired - Lifetime ES2545577T3 (es) | 2002-08-29 | 2003-08-27 | Método mejorado para el tratamiento con bisulfito |
| ES03019321T Expired - Lifetime ES2294231T3 (es) | 2002-08-29 | 2003-08-27 | Metodo mejorado para tratamiento por bisulfito. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES03019321T Expired - Lifetime ES2294231T3 (es) | 2002-08-29 | 2003-08-27 | Metodo mejorado para tratamiento por bisulfito. |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US9394332B2 (es) |
| EP (2) | EP1829886B1 (es) |
| JP (2) | JP5153048B2 (es) |
| CN (1) | CN1271081C (es) |
| AT (1) | ATE374782T1 (es) |
| AU (1) | AU2003236461B2 (es) |
| CA (1) | CA2438327C (es) |
| CY (1) | CY1107118T1 (es) |
| DE (1) | DE60316642T2 (es) |
| DK (2) | DK1394173T3 (es) |
| ES (2) | ES2545577T3 (es) |
| HU (1) | HUE027240T2 (es) |
| PT (1) | PT1394173E (es) |
| SI (2) | SI1394173T1 (es) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10154317B4 (de) * | 2001-10-26 | 2005-06-09 | Epigenomics Ag | Verfahren zum Nachweis von Cytosin-Methylierungen in immobilisierten DNA Proben |
| AU2003236461B2 (en) * | 2002-08-29 | 2009-05-28 | Epigenomics Ag | Improved method for bisulfite treatment |
| US7534873B2 (en) * | 2003-08-29 | 2009-05-19 | Applied Biosystems, Llc | Method and materials for quaternary amine catalyzed bisulfite conversion of cytosine to uracil |
| US7371526B2 (en) * | 2003-08-29 | 2008-05-13 | Applera Corporation | Method and materials for bisulfite conversion of cytosine to uracil |
| US7262013B2 (en) * | 2003-08-29 | 2007-08-28 | Applera Corporation | Bisulfite method |
| US7368239B2 (en) * | 2003-08-29 | 2008-05-06 | Applera Corporation | Method and materials for polyamine catalyzed bisulfite conversion of cytosine to uracil |
| DE602004021192D1 (de) | 2003-10-09 | 2009-07-02 | Epigenomics Ag | Verbesserte bisulfitkonversion von dna |
| WO2005100240A1 (ja) * | 2004-04-08 | 2005-10-27 | Toyo Boseki Kabushiki Kaisha | Dnaの脱アミノ化のための組成物及びメチル化dnaの検出方法 |
| EP1632578A1 (en) * | 2004-09-03 | 2006-03-08 | Roche Diagnostics GmbH | DNA decontamination method |
| CA2581140A1 (en) * | 2004-09-21 | 2006-03-30 | Applera Corporation | Methods of using sulfur nucleophiles as improved alternatives to sodium bisulfite for methylated dna analysis |
| US7658288B2 (en) | 2004-11-08 | 2010-02-09 | Applied Biosystems, Llc | Bisulfite conversion reagent |
| WO2006103111A2 (en) | 2005-04-01 | 2006-10-05 | Epigenomics Ag | Improved bisulfite conversion of dna |
| EP1963352B1 (en) * | 2005-12-14 | 2010-09-08 | Roche Diagnostics GmbH | New method for bisulfite treatment |
| US7820385B2 (en) * | 2006-03-22 | 2010-10-26 | The United States Of America As Represented By The Department Of Health And Human Services, Centers For Disease Control And Prevention | Method for retaining methylation pattern in globally amplified DNA |
| US20080213870A1 (en) * | 2007-03-01 | 2008-09-04 | Sean Wuxiong Cao | Methods for obtaining modified DNA from a biological specimen |
| WO2009088987A2 (en) * | 2008-01-03 | 2009-07-16 | The Johns Hopkins University | Compositions and methods for polynucleotide extraction and methylation detection |
| US9115386B2 (en) | 2008-09-26 | 2015-08-25 | Children's Medical Center Corporation | Selective oxidation of 5-methylcytosine by TET-family proteins |
| FR2940805B1 (fr) | 2009-01-05 | 2015-10-16 | Biomerieux Sa | Procede d'amplification et/ou de detection d'acides nucleiques, kits et utilisations de ce procede |
| EP3141616B1 (en) | 2011-07-29 | 2020-05-13 | Cambridge Epigenetix Limited | Methods for detection of nucleotide modification |
| US10563248B2 (en) | 2012-11-30 | 2020-02-18 | Cambridge Epigenetix Limited | Oxidizing agent for modified nucleotides |
| JP6681414B2 (ja) * | 2015-06-10 | 2020-04-15 | バイオカーティス エヌ ヴイ | メチル化dnaの改善された検出 |
| CN107922941A (zh) | 2015-06-15 | 2018-04-17 | 塞弗德公司 | 在自动化反应盒中DNA甲基化的整合的纯化和测量以及突变和/或mRNA表达水平的共同测量 |
| EP3551332B1 (en) | 2016-12-12 | 2024-01-10 | Cepheid | Integrated purification and measurement of dna methylation and co-measurement of mutations and/or mrna expression levels in an automated reaction cartridge |
| AU2019234843B2 (en) | 2018-03-13 | 2025-12-04 | Grail, Inc. | Anomalous fragment detection and classification |
| CN108265050A (zh) * | 2018-03-13 | 2018-07-10 | 普迈德(北京)科技有限公司 | 一种血浆直接亚硫酸氢盐转化的方法及其应用 |
| WO2019195268A2 (en) | 2018-04-02 | 2019-10-10 | Grail, Inc. | Methylation markers and targeted methylation probe panels |
| CA3111887A1 (en) | 2018-09-27 | 2020-04-02 | Grail, Inc. | Methylation markers and targeted methylation probe panel |
| EP3899953A1 (en) | 2018-12-21 | 2021-10-27 | Grail, Inc. | Source of origin deconvolution based on methylation fragments in cell-free-dna samples |
| DE102019118332B4 (de) | 2019-07-07 | 2022-04-07 | Ist Innuscreen Gmbh | Verfahren und testkit zur bisulfitmodifizierung von dna |
| EP4096694A4 (en) | 2020-01-30 | 2024-01-24 | Prognomiq Inc | LUNG BIOMARKERS AND THEIR METHODS OF USE |
| CN116157519A (zh) * | 2020-07-29 | 2023-05-23 | 精密科学公司 | 经磺化dna的纯化 |
| US20220328134A1 (en) | 2021-03-31 | 2022-10-13 | PrognomIQ, Inc. | Multi-omic assessment |
| US12387508B2 (en) | 2021-09-10 | 2025-08-12 | PrognomIQ, Inc. | Direct classification of raw biomolecule measurement data |
| EP4711762A1 (en) | 2021-09-13 | 2026-03-18 | Prognomiq Inc | Enhanced detection and quantitation of biomolecules |
| CN114317761A (zh) * | 2022-02-23 | 2022-04-12 | 厦门飞朔生物技术有限公司 | 一种宫颈癌相关基因甲基化检测方法 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| DK171161B1 (da) | 1985-03-28 | 1996-07-08 | Hoffmann La Roche | Fremgangsmåde til påvisning af forekomst eller fravær af mindst én specifik nukleinsyresekvens i en prøve eller til skelnen mellem to forskellige nukleinsyresekvenser i denne prøve |
| DE3724442A1 (de) | 1987-07-23 | 1989-02-02 | Europ Lab Molekularbiolog | Verfahren und vorrichtung zur reinigung von m-13-phagen-dna |
| IE61148B1 (en) | 1988-03-10 | 1994-10-05 | Ici Plc | Method of detecting nucleotide sequences |
| US5130238A (en) | 1988-06-24 | 1992-07-14 | Cangene Corporation | Enhanced nucleic acid amplification process |
| WO1990001069A1 (en) | 1988-07-20 | 1990-02-08 | Segev Diagnostics, Inc. | Process for amplifying and detecting nucleic acid sequences |
| AU640626B2 (en) | 1988-11-21 | 1993-09-02 | Dynal As | Nucleic acid probes |
| US5639611A (en) | 1988-12-12 | 1997-06-17 | City Of Hope | Allele specific polymerase chain reaction |
| US5234809A (en) | 1989-03-23 | 1993-08-10 | Akzo N.V. | Process for isolating nucleic acid |
| NL8900725A (nl) | 1989-03-23 | 1990-10-16 | Az Univ Amsterdam | Werkwijze en combinatie van middelen voor het isoleren van nucleinezuur. |
| US5137806A (en) | 1989-12-11 | 1992-08-11 | Board Of Regents, The University Of Texas System | Methods and compositions for the detection of sequences in selected DNA molecules |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| AU669398B2 (en) | 1992-11-13 | 1996-06-06 | Becton Dickinson & Company | Boron silicates aluminum silicates phosphosilicates and purification of DNA |
| US5438127A (en) | 1993-09-27 | 1995-08-01 | Becton Dickinson And Company | DNA purification by solid phase extraction using a PCl3 modified glass fiber membrane |
| US5503816A (en) | 1993-09-27 | 1996-04-02 | Becton Dickinson And Company | Silicate compounds for DNA purification |
| US5552277A (en) | 1994-07-19 | 1996-09-03 | The Johns Hopkins University School Of Medicine | Genetic diagnosis of prostate cancer |
| DE19520398B4 (de) | 1995-06-08 | 2009-04-16 | Roche Diagnostics Gmbh | Magnetisches Pigment |
| US5786146A (en) | 1996-06-03 | 1998-07-28 | The Johns Hopkins University School Of Medicine | Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids |
| EP0912766B2 (en) | 1996-06-04 | 2011-12-14 | University of Utah Research Foundation | Monitoring hybridization during pcr |
| CA2286573C (en) * | 1997-04-16 | 2004-10-26 | Immunological Associates Of Denver | Nucleic acid archiving |
| GB9714716D0 (en) * | 1997-07-11 | 1997-09-17 | Brax Genomics Ltd | Characterising nucleic acids |
| DE19743518A1 (de) | 1997-10-01 | 1999-04-15 | Roche Diagnostics Gmbh | Automatisierbare universell anwendbare Probenvorbereitungsmethode |
| DE59912604D1 (de) | 1998-02-04 | 2005-11-03 | Merck Patent Gmbh | Verfahren zur isolierung und aufreinigung von nucleinsäuren |
| JP3561235B2 (ja) | 1998-11-30 | 2004-09-02 | ロシュ ダイアグノスティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 核酸を精製するための磁性粒子 |
| DE19856064C2 (de) | 1998-12-04 | 2000-11-30 | Invitek Gmbh | Universelles Verfahren zur Isolierung von DNA aus beliebigen Ausgangsmaterialien |
| US6331393B1 (en) | 1999-05-14 | 2001-12-18 | University Of Southern California | Process for high-throughput DNA methylation analysis |
| US6423536B1 (en) | 1999-08-02 | 2002-07-23 | Molecular Dynamics, Inc. | Low volume chemical and biochemical reaction system |
| DK1232502T3 (da) * | 1999-11-17 | 2006-05-22 | Roche Diagnostics Gmbh | Magnetiske glaspartikler, fremgangsmåde til deres fremstilling samt anvendelser deraf |
| DE19958042A1 (de) | 1999-12-03 | 2001-06-21 | Invitek Gmbh | Oberflächenmodifizierte Trägermaterialien zur Bindung biologischer Materialien, Verfahren zu ihrer Herstellung und ihre Verwendung |
| DE10029915B4 (de) | 2000-06-19 | 2005-06-16 | Epigenomics Ag | Verfahren zum Nachweis von Cytosin-Methylierungen |
| DE10050942B4 (de) | 2000-10-10 | 2005-11-17 | Epigenomics Ag | Verfahren zum Nachweis von Cytosin-Methylierungen |
| US20030152950A1 (en) | 2001-06-27 | 2003-08-14 | Garner Harold R. | Identification of chemically modified polymers |
| WO2003012124A2 (en) * | 2001-07-31 | 2003-02-13 | New York Institute Of Technology | Methods for immobilizing molecules to a solid phase and uses thereof |
| DE10154317B4 (de) | 2001-10-26 | 2005-06-09 | Epigenomics Ag | Verfahren zum Nachweis von Cytosin-Methylierungen in immobilisierten DNA Proben |
| AU2003236461B2 (en) | 2002-08-29 | 2009-05-28 | Epigenomics Ag | Improved method for bisulfite treatment |
| EP1394172A1 (en) | 2002-08-29 | 2004-03-03 | Boehringer Mannheim Gmbh | Improved method for bisulfite treatment |
| US7501240B2 (en) * | 2003-12-02 | 2009-03-10 | Roche Molecular Systems, Inc. | Method for bisulfite treatment |
| EP1963352B1 (en) * | 2005-12-14 | 2010-09-08 | Roche Diagnostics GmbH | New method for bisulfite treatment |
-
2003
- 2003-08-25 AU AU2003236461A patent/AU2003236461B2/en not_active Ceased
- 2003-08-25 US US10/647,720 patent/US9394332B2/en active Active
- 2003-08-27 ES ES07012188.4T patent/ES2545577T3/es not_active Expired - Lifetime
- 2003-08-27 EP EP07012188.4A patent/EP1829886B1/en not_active Revoked
- 2003-08-27 SI SI200331015T patent/SI1394173T1/sl unknown
- 2003-08-27 EP EP03019321A patent/EP1394173B9/en not_active Expired - Lifetime
- 2003-08-27 PT PT03019321T patent/PT1394173E/pt unknown
- 2003-08-27 SI SI200332443T patent/SI1829886T1/sl unknown
- 2003-08-27 DK DK03019321T patent/DK1394173T3/da active
- 2003-08-27 DK DK07012188.4T patent/DK1829886T3/en active
- 2003-08-27 DE DE60316642T patent/DE60316642T2/de not_active Expired - Lifetime
- 2003-08-27 ES ES03019321T patent/ES2294231T3/es not_active Expired - Lifetime
- 2003-08-27 HU HUE07012188A patent/HUE027240T2/en unknown
- 2003-08-27 AT AT03019321T patent/ATE374782T1/de active
- 2003-08-28 CN CNB031602835A patent/CN1271081C/zh not_active Expired - Fee Related
- 2003-08-28 CA CA002438327A patent/CA2438327C/en not_active Expired - Fee Related
- 2003-08-29 JP JP2003306141A patent/JP5153048B2/ja not_active Expired - Lifetime
-
2008
- 2008-01-02 CY CY20081100002T patent/CY1107118T1/el unknown
-
2009
- 2009-02-13 JP JP2009031400A patent/JP5310059B2/ja not_active Expired - Lifetime
-
2015
- 2015-08-24 US US14/833,738 patent/US9868756B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1829886A3 (en) | 2008-10-15 |
| DK1829886T3 (en) | 2015-08-17 |
| CN1271081C (zh) | 2006-08-23 |
| US9868756B2 (en) | 2018-01-16 |
| DK1394173T3 (da) | 2008-02-04 |
| EP1394173B9 (en) | 2008-10-15 |
| ATE374782T1 (de) | 2007-10-15 |
| SI1394173T1 (sl) | 2008-02-29 |
| US20160068888A1 (en) | 2016-03-10 |
| EP1394173A1 (en) | 2004-03-03 |
| DE60316642T2 (de) | 2008-01-31 |
| AU2003236461B2 (en) | 2009-05-28 |
| US9394332B2 (en) | 2016-07-19 |
| JP2004089195A (ja) | 2004-03-25 |
| CA2438327A1 (en) | 2004-02-29 |
| CY1107118T1 (el) | 2012-10-24 |
| EP1829886A2 (en) | 2007-09-05 |
| EP1394173B1 (en) | 2007-10-03 |
| JP2009106304A (ja) | 2009-05-21 |
| ES2294231T3 (es) | 2008-04-01 |
| CA2438327C (en) | 2008-04-15 |
| HUE027240T2 (en) | 2016-10-28 |
| DE60316642D1 (de) | 2007-11-15 |
| US20040241704A1 (en) | 2004-12-02 |
| HK1062688A1 (en) | 2004-11-19 |
| PT1394173E (pt) | 2007-11-28 |
| JP5153048B2 (ja) | 2013-02-27 |
| SI1829886T1 (sl) | 2015-12-31 |
| CN1495192A (zh) | 2004-05-12 |
| EP1829886B1 (en) | 2015-07-29 |
| JP5310059B2 (ja) | 2013-10-09 |
| AU2003236461A1 (en) | 2004-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2545577T3 (es) | Método mejorado para el tratamiento con bisulfito | |
| ATE440965T1 (de) | Neue zusammensetzung und methode zur 'hot start' nukleinsäureamplifizierung | |
| EP2272952B8 (en) | Thermostable or thermoactive DNA polymerase with attenuated 3'-5' exonuclease activity | |
| ATE432365T1 (de) | Verfahren, kits und reagenzien zur nukleinsäuresequenzierung | |
| DK1499738T3 (da) | Recombinase-polymerease-amplifikation | |
| ATE427361T1 (de) | Verfahren zur dna-amplifikation und - sequenzierung | |
| ATE547537T1 (de) | Verfahren zur bestimmung der dna-methylierung in blut- oder urinproben | |
| WO2004013346A3 (en) | Methods and compositions for genotyping | |
| DE60230672D1 (de) | Nukleinsäureanreicherung | |
| DE69942351D1 (de) | Methoden und Reagenzien zur Erhaltung der RNA in Zellen und Geweben | |
| EP1845160A4 (en) | NUCLEOTIDE-amplification | |
| IS6887A (is) | Aðferð til að greina sýtósín metýleringarmynstur sem hafa mikla næmni | |
| ATE364718T1 (de) | Verfahren zur vervielfältigung von nukleinsäure | |
| DE60238493D1 (de) | Is von seltenen zellen verwendete markierte zellen | |
| ATE323182T1 (de) | Universelle methode und zusammensetzung zur schnellen lysierung von zellen zur freisetzung von nukleinsäuren und ihre detektion | |
| ATE315666T1 (de) | Methode zur amplifizierung und möglicher charakterisierung von nukleinsäuren | |
| AU2003226052A8 (en) | Methods for detecting abnormally methylated nucleic acid in heterogeneous biological samples | |
| ATE396282T1 (de) | Verfahren zum kontaminationsschutz von dna- amplifikationsreaktionen zur methylierungsanalyse durch modifizierte vorbehandlung der nukleinsäuren | |
| CA2477574A1 (en) | Melting temperature dependent dna amplification | |
| DE602005016221D1 (de) | Durch gefrierschutzprotein verbesserte nukleinsäureamplifikation | |
| PT1490383E (pt) | Métodos e composições para identificar e caracterizar a hepatite c | |
| WO2003016550A3 (en) | Compositions and methods comprising control nucleic acid | |
| WO2004067775A3 (en) | Method for the detection of cytosine methylation patterns with high sensitivity | |
| ATE263129T1 (de) | Mischung zur beschleunigung der kompostierung | |
| EP2042612A3 (en) | A novel nucleotide mixture for improved nucleic acid amplification performance |